109105-51-3

Basic information

• Product Name: 1-Benzyl-hexahydro-4H-azepin-4-amine
• Synonyms: 1-BENZYL-HEXAHYDRO-4H-AZEPIN-4-AMINE;1-benzylazepan-4-amine;1H-Azepin-4-aMine, hexahydro-1-(phenylMethyl)-;hexahydro-1-(phenylmethyl)-1H-Azepin-4-amine
• CAS NO: 109105-51-3
• Molecular Formula: C₁₃H₂₀N₂
• Molecular Weight: 204.31
• Product Categories: pharmacetical
• Mol File: 109105-51-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 300.1 °C at 760 mmHg
• Flash Point: 125.1 °C
• Appearance: /
• Density: 1.015 g/cm³
• Vapor Pressure: 0.00114mmHg at 25°C
• Refractive Index: 1.548
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-Benzyl-hexahydro-4H-azepin-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Benzyl-hexahydro-4H-azepin-4-amine(109105-51-3)
• EPA Substance Registry System: 1-Benzyl-hexahydro-4H-azepin-4-amine(109105-51-3)

Safety Data

• Hazardous Substances Data: 109105-51-3(Hazardous Substances Data)

Usage

General Description

1-Benzyl-hexahydro-4H-azepin-4-amine is a chemical compound with molecular formula C14H22N2. It falls under the category of organic compounds known as benzylamines, which are those containing a benzylamine group with a benzene ring connected to an amine group. This chemical is used primarily in scientific research, often in the field of chemistry. Its characteristics and effects have not been widely explored yet, which makes it mostly useful to those studying different chemical reactions and developing new chemical compounds. Specific properties like boiling or melting points, density, or its potential uses in industrial applications have not been widely reported.

InChI:InChI=1/C13H20N2/c14-13-7-4-9-15(10-8-13)11-12-5-2-1-3-6-12/h1-3,5-6,13H,4,7-11,14H2

Upstream product

• 82102-84-9 1-benzyl-4-azepanone oxime 
• 1208-75-9 1-benzylazepan-4-one 

Downstream Products

• 108724-15-8 hexahydro-azepin-4-ylamine 
• 1217488-74-8 C₁₈H₂₃N₃O₄ 
• 1365212-48-1 C₁₅H₂₀N₂O₂ 
• 1365212-28-7 C₁₉H₂₃FN₂O₂S 
• 1365212-26-5 C₁₆H₂₄N₂O 
• 1365212-25-4 C₁₅H₂₂N₂O 

Relevant articles and documents

Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs

A series of analogs of DM235 and MN19, characterized by rings with different size, have been prepared and evaluated for their nootropic activity in the mouse passive-avoidance test. It was found that the optimal ring size for the analogs of DM235, showing endocyclic both amidic groups, is 6 or 7 atoms. For the compounds structurally related to MN19, carrying an exocyclic amide group, the piperidine ring is the moiety which gives the most interesting compounds.

Pyrimido[5,4]-dipyrimidines, pharmaceuticals containing them, their use and processes for the preparation thereof

Pyrimido[5,4-d]pyrimidines of the general formula [Figure] which have an inhibitory effect on signal transduction mediated by tyrosine kinases, their use for the treatment of disorders, in particular of oncoses, and their preparation. Exemplary compounds are: 4-[(3-Chloro-4-fluorophenyl)amino]-6-[1-methyl-4-piperidinylamino]pyrimido[5,4-d]pyrimidine, and 4-[(3-Chloro-4-fluorophenyl)amino]-6-[trans-4-dimethyl-aminocycohexylamino]pyrimido[5,4-d]pyrimidine.